MedPath

四川巴中普瑞制药有限公司

Ownership
-
Established
2000-03-09
Employees
-
Market Cap
-
Website
sclzzyyxgs.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

76

NMPA:76

Drug Approvals

穿心莲片

Approval Number
国药准字Z51021625
Approval Date
May 19, 2021
NMPA

牛黄解毒片

Approval Number
国药准字Z51021628
Approval Date
May 19, 2021
NMPA

益母草颗粒

Approval Number
国药准字Z51022132
Approval Date
May 19, 2021
NMPA

健脾糕片

Approval Number
国药准字Z51022113
Approval Date
May 19, 2021
NMPA

川贝枇杷糖浆

Approval Number
国药准字Z51022357
Approval Date
May 19, 2021
NMPA

利胆排石片

Approval Number
国药准字Z51021627
Approval Date
May 19, 2021
NMPA

银翘解毒片

Approval Number
国药准字Z51022123
Approval Date
May 19, 2021
NMPA

三果汤颗粒

Approval Number
国药准字Z20030061
Approval Date
May 19, 2021
NMPA

三勒浆口服液

Approval Number
国药准字B20020582
Approval Date
May 19, 2021
NMPA

麻杏止咳糖浆

Approval Number
国药准字Z51022312
Approval Date
May 19, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.